PubMed

A randomized trial of a strategy for increasing high-density lipoprotein cholesterol levels: effects on progression of coronary heart disease and clinical events.

Whitney EJ, Krasuski RA, Personius BE, Michalek JE, Maranian AM, Kolasa MW, Monick E, Brown BG, Gotto AM Jr.

Ann Intern Med. 2005 Jan 18;142(2):95-104.PMID: 15657157 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of combination therapy with lipid-reducing drugs in patients with coronary heart disease and "normal" cholesterol levels. A randomized, placebo-controlled trial. Harvard Atherosclerosis Reversibility Project (HARP) Study Group.

Pasternak RC, Brown LE, Stone PH, Silverman DI, Gibson CM, Sacks FM.

Ann Intern Med. 1996 Oct 1;125(7):529-40.PMID: 8815751 [PubMed - indexed for MEDLINE]Related articlesFree article

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group.

Rubins HB, Robins SJ, Collins D, Fye CL, Anderson JW, Elam MB, Faas FH, Linares E, Schaefer EJ, Schectman G, Wilt TJ, Wittes J.

N Engl J Med. 1999 Aug 5;341(6):410-8.PMID: 10438259 [PubMed - indexed for MEDLINE]Related articlesFree article

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.

Downs JR, Clearfield M, Weis S, Whitney E, Shapiro DR, Beere PA, Langendorfer A, Stein EA, Kruyer W, Gotto AM Jr.

JAMA. 1998 May 27;279(20):1615-22.PMID: 9613910 [PubMed - indexed for MEDLINE]Related articlesFree article

Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial.

Robins SJ, Collins D, Wittes JT, Papademetriou V, Deedwania PC, Schaefer EJ, McNamara JR, Kashyap ML, Hershman JM, Wexler LF, Rubins HB; VA-HIT Study Group. Veterans Affairs High-Density Lipoprotein Intervention Trial.

JAMA. 2001 Mar 28;285(12):1585-91.PMID: 11268266 [PubMed - indexed for MEDLINE]Related articlesFree article

Summaries for patients. Targeting cholesterol treatment toward increasing high-density lipoprotein levels.

[No authors listed]

Ann Intern Med. 2005 Jan 18;142(2):I46. No abstract available. PMID: 15657152 [PubMed - indexed for MEDLINE]Related articlesFree article

Extended-release niacin vs gemfibrozil for the treatment of low levels of high-density lipoprotein cholesterol. Niaspan-Gemfibrozil Study Group.

Guyton JR, Blazing MA, Hagar J, Kashyap ML, Knopp RH, McKenney JM, Nash DT, Nash SD.

Arch Intern Med. 2000 Apr 24;160(8):1177-84.PMID: 10789612 [PubMed - indexed for MEDLINE]Related articlesFree article

[Lipid intervention and coronary heart disease in men less than 56 years of age. The Coronary Intervention Study: CIS]

Rensing UF, Bestehorn HP, Roskamm H, Petersen J, Betz P, Spinder M, Benesch L, Schemeitat K, Blümchen G, Claus J, Wieland H, Böcker JF, Neiss A, Stiepel E, Mathes P, Kappenberger L, Braunagel K, Peters K, Meister G, Samek L, Schuon J, Leimenstoll B, Kiefer H.

Z Kardiol. 1999 Apr;88(4):270-82. German. PMID: 10408031 [PubMed - indexed for MEDLINE]Related articles

Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease.

Brown BG, Zhao XQ, Chait A, Fisher LD, Cheung MC, Morse JS, Dowdy AA, Marino EK, Bolson EL, Alaupovic P, Frohlich J, Albers JJ.

N Engl J Med. 2001 Nov 29;345(22):1583-92.PMID: 11757504 [PubMed - indexed for MEDLINE]Related articlesFree article

Angiographic assessment of effects of bezafibrate on progression of coronary artery disease in young male postinfarction patients.

Ericsson CG, Hamsten A, Nilsson J, Grip L, Svane B, de Faire U.

Lancet. 1996 Mar 30;347(9005):849-53.PMID: 8622389 [PubMed - indexed for MEDLINE]Related articles

Cost-effectiveness of gemfibrozil for coronary heart disease patients with low levels of high-density lipoprotein cholesterol: the Department of Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial.

Nyman JA, Martinson MS, Nelson D, Nugent S, Collins D, Wittes J, Fye CL, Wilt TJ, Robins SJ, Bloomfield Rubins H; VA-HIT Study Group.

Arch Intern Med. 2002 Jan 28;162(2):177-82.PMID: 11802751 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range. Results of the Cholesterol and Recurrent Events (CARE) trial.

Lewis SJ, Moye LA, Sacks FM, Johnstone DE, Timmis G, Mitchell J, Limacher M, Kell S, Glasser SP, Grant J, Davis BR, Pfeffer MA, Braunwald E.

Ann Intern Med. 1998 Nov 1;129(9):681-9.PMID: 9841599 [PubMed - indexed for MEDLINE]Related articlesFree article

Prevention of the angiographic progression of coronary and vein-graft atherosclerosis by gemfibrozil after coronary bypass surgery in men with low levels of HDL cholesterol. Lopid Coronary Angiography Trial (LOCAT) Study Group.

Frick MH, Syvänne M, Nieminen MS, Kauma H, Majahalme S, Virtanen V, Kesäniemi YA, Pasternack A, Taskinen MR.

Circulation. 1997 Oct 7;96(7):2137-43.PMID: 9337181 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of gemfibrozil +/- niacin +/- cholestyramine on endothelial function in patients with serum low-density lipoprotein cholesterol levels <160 mg/dl and high-density lipoprotein cholesterol levels <40 mg/dl.

Andrews TC, Whitney EJ, Green G, Kalenian R, Personius BE.

Am J Cardiol. 1997 Oct 1;80(7):831-5.PMID: 9381993 [PubMed - indexed for MEDLINE]Related articles

High-density lipoprotein cholesterol as an independent risk factor in cardiovascular disease: assessing the data from Framingham to the Veterans Affairs High--Density Lipoprotein Intervention Trial.

Boden WE.

Am J Cardiol. 2000 Dec 21;86(12A):19L-22L. Review.PMID: 11374850 [PubMed - indexed for MEDLINE]Related articles

Effect of niacin on lipid and lipoprotein levels and glycemic control in patients with diabetes and peripheral arterial disease: the ADMIT study: A randomized trial. Arterial Disease Multiple Intervention Trial.

Elam MB, Hunninghake DB, Davis KB, Garg R, Johnson C, Egan D, Kostis JB, Sheps DS, Brinton EA.

JAMA. 2000 Sep 13;284(10):1263-70.PMID: 10979113 [PubMed - indexed for MEDLINE]Related articlesFree article

A study to determine the response of coronary atherosclerosis to raising low high density lipoprotein cholesterol with a fibric-acid derivative in men after coronary bypass surgery. The rationale, design, and baseline characteristics of the LOCAT Study. Lopid Coronary Angiography Trial.

Syvänne M, Taskinen MR, Nieminen, Manninen V, Kesäniemi YA, Pasternack A, Nawrocki JW, Haber H, Frick MH.

Control Clin Trials. 1997 Feb;18(1):93-119.PMID: 9055055 [PubMed - indexed for MEDLINE]Related articles

Effects of hormone replacement therapy on serum lipids in elderly women. a randomized, placebo-controlled trial.

Binder EF, Williams DB, Schechtman KB, Jeffe DB, Kohrt WM.

Ann Intern Med. 2001 May 1;134(9 Pt 1):754-60.PMID: 11329233 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of regular and extended-release gemfibrozil on plasma lipoproteins and apolipoproteins in hypercholesterolemic patients with decreased HDL cholesterol levels.

Schaefer EJ, Lamon-Fava S, Cole T, Sprecher DL, Cilla DD Jr, Balagtas CC, Rowan JP, Black DM.

Atherosclerosis. 1996 Nov 15;127(1):113-22.PMID: 9006811 [PubMed - indexed for MEDLINE]Related articles

Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.

Pearson T, Denke M, McBride P, Battisti WP, Brady WE, Palmisano J.

Am J Geriatr Pharmacother. 2005 Dec;3(4):218-28.PMID: 16503317 [PubMed - indexed for MEDLINE]Related articles